ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 23.64 Delayed Data As of Sep 26 |  +0.35 / +1.50%Today’s Change | 13.73 Today|||52-Week Range 33.99 | +48.49% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -164.4M | -271.4M | -289.4M | -245.2M | |
| Depreciation | 647.0K | 1.8M | 2.7M | 3.0M | ||
| Total Other Cash Flow | 37.9M | 54.8M | 75.2M | 82.9M | ||
| Funds From Operations | -125.9M | -214.8M | -211.4M | -159.3M | ||
| Funds From/For Other Operating Expenses | -4.5M | -6.4M | 6.3M | 8.2M | ||
| Net Cash Flow - Operating Activities | -121.4M | -208.4M | -217.8M | -167.5M | ||
| Investing | Increase In Investments | -269.9M | -683.4M | -478.8M | -331.1M | |
| Decrease In Investments | 419.2M | 430.9M | 572.1M | 261.7M | ||
| Capital Expenditures | -2.1M | -1.5M | -812.0K | -2.1M | ||
| Fixed Asset Disposal | 0.00 | -- | -- | 44.0K | ||
| Net Cash Flow Investing | 147.2M | -261.9M | 92.5M | -71.5M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 14.5M | 518.9M | 31.2M | 306.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 247.0K | 14.9M | 0.00 | 0.00 | ||
| Other Uses - Financing | 292.0K | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | 14.5M | 533.8M | 31.2M | 306.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 7.0K | 2.0K | -6.0K | 3.0K | |
| Net Change In Cash | 40.3M | 63.5M | -94.1M | 67.7M | ||
